Tirzepatide vs semaglutide for metabolic optimization in patients with cancer: A target trial emulation study.
Year: 2025
Type: conference-abstract
Source: JCO Oncology Practice
Authors: Omer Sayed Ashruf, Nathan Cuttica, Jalal Jwayyed, Nanak Dhillon, Michael Nicolaou, Akriti G. Jain, David Kaelber, Abhay Singh
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414913288
